Click for best price
HIV Therapy Market Size, Share 2022
HIV Therapy involves taking a combination of HIV medicines . HIV Therapy is recommended for everyone who has HIV. HIV Therapy cannot cure HIV, but HIV medicines help people with HIV live longer, healthier lives.
This report contains market size and forecasts of HIV Therapy in global, including the following market information:
Global HIV Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global HIV Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five HIV Therapy companies in 2021 (%)
The global HIV Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Integrase Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of HIV Therapy include ViiV Healthcare, Gilead Sciences, Inc., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc. and Genentech, Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the HIV Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Therapy Market, by Drug Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global HIV Therapy Market Segment Percentages, by Drug Type, 2021 (%)
Integrase Inhibitors
Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Combination HIV Medicines
Others
Global HIV Therapy Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global HIV Therapy Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global HIV Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global HIV Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HIV Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies HIV Therapy revenues share in global market, 2021 (%)
Key companies HIV Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies HIV Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ViiV Healthcare
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Merck Sharp & Dohme Corp.
Bristol-Myers Squibb Company
Janssen Pharmaceuticals, Inc.
Boehringer Ingelheim International GmbH
AbbVie Inc.
Genentech, Inc.
Mylan N.V.
| Report Attributes |
Report Details |
| Report Title |
HIV Therapy Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
77 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 HIV Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Drug Type
1.2.2 Market by Application
1.3 Global HIV Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HIV Therapy Overall Market Size
2.1 Global HIV Therapy Market Size: 2021 VS 2028
2.2 Global HIV Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global HIV Therapy Sales: 2017-2028
3 Company Landscape
3.1 Top HIV Therapy Players in Global Market
3.2 Top Global HIV Therapy Companies Ranked by Revenue
3.3 Global HIV Therapy Revenue by Companies
3.4 Global HIV Therapy Sales by Companies
3.5 Global HIV Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 HIV Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers HIV Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 HIV Therapy Players in Global Market
3.8.1 List of Global Tier 1 HIV Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 HIV Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Drug Type - Global HIV Therapy Market Size Markets, 2021 & 2028
4.1.2 Integrase Inhibitors
4.1.3 Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
4.1.4 Combination HIV Medicines
4.1.5 Others
4.2 By Drug Type - Global HIV Therapy Revenue & Forecasts
4.2.1 By Drug Type - Global HIV Therapy Revenue, 2017-2022
4.2.2 By Drug Type - Global HIV Therapy Revenue, 2023-2028
4.2.3 By Drug Type - Global HIV Therapy Revenue Market Share, 2017-2028
4.3 By Drug Type - Global HIV Therapy Sales & Forecasts
4.3.1 By Drug Type - Global HIV Therapy Sales, 2017-2022
4.3.2 By Drug Type - Global HIV Therapy Sales, 2023-2028
4.3.3 By Drug Type - Global HIV Therapy Sales Market Share, 2017-2028
4.4 By Drug Type - Global HIV Therapy Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global HIV Therapy Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Others
5.2 By Application - Global HIV Therapy Revenue & Forecasts
5.2.1 By Application - Global HIV Therapy Revenue, 2017-2022
5.2.2 By Application - Global HIV Therapy Revenue, 2023-2028
5.2.3 By Application - Global HIV Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global HIV Therapy Sales & Forecasts
5.3.1 By Application - Global HIV Therapy Sales, 2017-2022
5.3.2 By Application - Global HIV Therapy Sales, 2023-2028
5.3.3 By Application - Global HIV Therapy Sales Market Share, 2017-2028
5.4 By Application - Global HIV Therapy Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global HIV Therapy Market Size, 2021 & 2028
6.2 By Region - Global HIV Therapy Revenue & Forecasts
6.2.1 By Region - Global HIV Therapy Revenue, 2017-2022
6.2.2 By Region - Global HIV Therapy Revenue, 2023-2028
6.2.3 By Region - Global HIV Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global HIV Therapy Sales & Forecasts
6.3.1 By Region - Global HIV Therapy Sales, 2017-2022
6.3.2 By Region - Global HIV Therapy Sales, 2023-2028
6.3.3 By Region - Global HIV Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America HIV Therapy Revenue, 2017-2028
6.4.2 By Country - North America HIV Therapy Sales, 2017-2028
6.4.3 US HIV Therapy Market Size, 2017-2028
6.4.4 Canada HIV Therapy Market Size, 2017-2028
6.4.5 Mexico HIV Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe HIV Therapy Revenue, 2017-2028
6.5.2 By Country - Europe HIV Therapy Sales, 2017-2028
6.5.3 Germany HIV Therapy Market Size, 2017-2028
6.5.4 France HIV Therapy Market Size, 2017-2028
6.5.5 U.K. HIV Therapy Market Size, 2017-2028
6.5.6 Italy HIV Therapy Market Size, 2017-2028
6.5.7 Russia HIV Therapy Market Size, 2017-2028
6.5.8 Nordic Countries HIV Therapy Market Size, 2017-2028
6.5.9 Benelux HIV Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia HIV Therapy Revenue, 2017-2028
6.6.2 By Region - Asia HIV Therapy Sales, 2017-2028
6.6.3 China HIV Therapy Market Size, 2017-2028
6.6.4 Japan HIV Therapy Market Size, 2017-2028
6.6.5 South Korea HIV Therapy Market Size, 2017-2028
6.6.6 Southeast Asia HIV Therapy Market Size, 2017-2028
6.6.7 India HIV Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America HIV Therapy Revenue, 2017-2028
6.7.2 By Country - South America HIV Therapy Sales, 2017-2028
6.7.3 Brazil HIV Therapy Market Size, 2017-2028
6.7.4 Argentina HIV Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa HIV Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa HIV Therapy Sales, 2017-2028
6.8.3 Turkey HIV Therapy Market Size, 2017-2028
6.8.4 Israel HIV Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia HIV Therapy Market Size, 2017-2028
6.8.6 UAE HIV Therapy Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 ViiV Healthcare
7.1.1 ViiV Healthcare Corporate Summary
7.1.2 ViiV Healthcare Business Overview
7.1.3 ViiV Healthcare HIV Therapy Major Product Offerings
7.1.4 ViiV Healthcare HIV Therapy Sales and Revenue in Global (2017-2022)
7.1.5 ViiV Healthcare Key News
7.2 Gilead Sciences, Inc.
7.2.1 Gilead Sciences, Inc. Corporate Summary
7.2.2 Gilead Sciences, Inc. Business Overview
7.2.3 Gilead Sciences, Inc. HIV Therapy Major Product Offerings
7.2.4 Gilead Sciences, Inc. HIV Therapy Sales and Revenue in Global (2017-2022)
7.2.5 Gilead Sciences, Inc. Key News
7.3 GlaxoSmithKline Plc
7.3.1 GlaxoSmithKline Plc Corporate Summary
7.3.2 GlaxoSmithKline Plc Business Overview
7.3.3 GlaxoSmithKline Plc HIV Therapy Major Product Offerings
7.3.4 GlaxoSmithKline Plc HIV Therapy Sales and Revenue in Global (2017-2022)
7.3.5 GlaxoSmithKline Plc Key News
7.4 Merck Sharp & Dohme Corp.
7.4.1 Merck Sharp & Dohme Corp. Corporate Summary
7.4.2 Merck Sharp & Dohme Corp. Business Overview
7.4.3 Merck Sharp & Dohme Corp. HIV Therapy Major Product Offerings
7.4.4 Merck Sharp & Dohme Corp. HIV Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Merck Sharp & Dohme Corp. Key News
7.5 Bristol-Myers Squibb Company
7.5.1 Bristol-Myers Squibb Company Corporate Summary
7.5.2 Bristol-Myers Squibb Company Business Overview
7.5.3 Bristol-Myers Squibb Company HIV Therapy Major Product Offerings
7.5.4 Bristol-Myers Squibb Company HIV Therapy Sales and Revenue in Global (2017-2022)
7.5.5 Bristol-Myers Squibb Company Key News
7.6 Janssen Pharmaceuticals, Inc.
7.6.1 Janssen Pharmaceuticals, Inc. Corporate Summary
7.6.2 Janssen Pharmaceuticals, Inc. Business Overview
7.6.3 Janssen Pharmaceuticals, Inc. HIV Therapy Major Product Offerings
7.6.4 Janssen Pharmaceuticals, Inc. HIV Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Janssen Pharmaceuticals, Inc. Key News
7.7 Boehringer Ingelheim International GmbH
7.7.1 Boehringer Ingelheim International GmbH Corporate Summary
7.7.2 Boehringer Ingelheim International GmbH Business Overview
7.7.3 Boehringer Ingelheim International GmbH HIV Therapy Major Product Offerings
7.7.4 Boehringer Ingelheim International GmbH HIV Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Boehringer Ingelheim International GmbH Key News
7.8 AbbVie Inc.
7.8.1 AbbVie Inc. Corporate Summary
7.8.2 AbbVie Inc. Business Overview
7.8.3 AbbVie Inc. HIV Therapy Major Product Offerings
7.8.4 AbbVie Inc. HIV Therapy Sales and Revenue in Global (2017-2022)
7.8.5 AbbVie Inc. Key News
7.9 Genentech, Inc.
7.9.1 Genentech, Inc. Corporate Summary
7.9.2 Genentech, Inc. Business Overview
7.9.3 Genentech, Inc. HIV Therapy Major Product Offerings
7.9.4 Genentech, Inc. HIV Therapy Sales and Revenue in Global (2017-2022)
7.9.5 Genentech, Inc. Key News
7.10 Mylan N.V.
7.10.1 Mylan N.V. Corporate Summary
7.10.2 Mylan N.V. Business Overview
7.10.3 Mylan N.V. HIV Therapy Major Product Offerings
7.10.4 Mylan N.V. HIV Therapy Sales and Revenue in Global (2017-2022)
7.10.5 Mylan N.V. Key News
8 Global HIV Therapy Production Capacity, Analysis
8.1 Global HIV Therapy Production Capacity, 2017-2028
8.2 HIV Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global HIV Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HIV Therapy Supply Chain Analysis
10.1 HIV Therapy Industry Value Chain
10.2 HIV Therapy Upstream Market
10.3 HIV Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 HIV Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of HIV Therapy in Global Market
Table 2. Top HIV Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global HIV Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global HIV Therapy Revenue Share by Companies, 2017-2022
Table 5. Global HIV Therapy Sales by Companies, (K Units), 2017-2022
Table 6. Global HIV Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers HIV Therapy Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers HIV Therapy Product Type
Table 9. List of Global Tier 1 HIV Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HIV Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Drug Type ? Global HIV Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Drug Type - Global HIV Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Drug Type - Global HIV Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Drug Type - Global HIV Therapy Sales (K Units), 2017-2022
Table 15. By Drug Type - Global HIV Therapy Sales (K Units), 2023-2028
Table 16. By Application ? Global HIV Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global HIV Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global HIV Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global HIV Therapy Sales (K Units), 2017-2022
Table 20. By Application - Global HIV Therapy Sales (K Units), 2023-2028
Table 21. By Region ? Global HIV Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global HIV Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global HIV Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global HIV Therapy Sales (K Units), 2017-2022
Table 25. By Region - Global HIV Therapy Sales (K Units), 2023-2028
Table 26. By Country - North America HIV Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America HIV Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America HIV Therapy Sales, (K Units), 2017-2022
Table 29. By Country - North America HIV Therapy Sales, (K Units), 2023-2028
Table 30. By Country - Europe HIV Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe HIV Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe HIV Therapy Sales, (K Units), 2017-2022
Table 33. By Country - Europe HIV Therapy Sales, (K Units), 2023-2028
Table 34. By Region - Asia HIV Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia HIV Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia HIV Therapy Sales, (K Units), 2017-2022
Table 37. By Region - Asia HIV Therapy Sales, (K Units), 2023-2028
Table 38. By Country - South America HIV Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America HIV Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America HIV Therapy Sales, (K Units), 2017-2022
Table 41. By Country - South America HIV Therapy Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa HIV Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa HIV Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa HIV Therapy Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa HIV Therapy Sales, (K Units), 2023-2028
Table 46. ViiV Healthcare Corporate Summary
Table 47. ViiV Healthcare HIV Therapy Product Offerings
Table 48. ViiV Healthcare HIV Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Gilead Sciences, Inc. Corporate Summary
Table 50. Gilead Sciences, Inc. HIV Therapy Product Offerings
Table 51. Gilead Sciences, Inc. HIV Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. GlaxoSmithKline Plc Corporate Summary
Table 53. GlaxoSmithKline Plc HIV Therapy Product Offerings
Table 54. GlaxoSmithKline Plc HIV Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Merck Sharp & Dohme Corp. Corporate Summary
Table 56. Merck Sharp & Dohme Corp. HIV Therapy Product Offerings
Table 57. Merck Sharp & Dohme Corp. HIV Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Bristol-Myers Squibb Company Corporate Summary
Table 59. Bristol-Myers Squibb Company HIV Therapy Product Offerings
Table 60. Bristol-Myers Squibb Company HIV Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Janssen Pharmaceuticals, Inc. Corporate Summary
Table 62. Janssen Pharmaceuticals, Inc. HIV Therapy Product Offerings
Table 63. Janssen Pharmaceuticals, Inc. HIV Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Boehringer Ingelheim International GmbH Corporate Summary
Table 65. Boehringer Ingelheim International GmbH HIV Therapy Product Offerings
Table 66. Boehringer Ingelheim International GmbH HIV Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. AbbVie Inc. Corporate Summary
Table 68. AbbVie Inc. HIV Therapy Product Offerings
Table 69. AbbVie Inc. HIV Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Genentech, Inc. Corporate Summary
Table 71. Genentech, Inc. HIV Therapy Product Offerings
Table 72. Genentech, Inc. HIV Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Mylan N.V. Corporate Summary
Table 74. Mylan N.V. HIV Therapy Product Offerings
Table 75. Mylan N.V. HIV Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. HIV Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global HIV Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global HIV Therapy Production by Region, 2017-2022 (K Units)
Table 79. Global HIV Therapy Production by Region, 2023-2028 (K Units)
Table 80. HIV Therapy Market Opportunities & Trends in Global Market
Table 81. HIV Therapy Market Drivers in Global Market
Table 82. HIV Therapy Market Restraints in Global Market
Table 83. HIV Therapy Raw Materials
Table 84. HIV Therapy Raw Materials Suppliers in Global Market
Table 85. Typical HIV Therapy Downstream
Table 86. HIV Therapy Downstream Clients in Global Market
Table 87. HIV Therapy Distributors and Sales Agents in Global Market
List of Figures
Figure 1. HIV Therapy Segment by Drug Type
Figure 2. HIV Therapy Segment by Application
Figure 3. Global HIV Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global HIV Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global HIV Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. HIV Therapy Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by HIV Therapy Revenue in 2021
Figure 9. By Drug Type - Global HIV Therapy Sales Market Share, 2017-2028
Figure 10. By Drug Type - Global HIV Therapy Revenue Market Share, 2017-2028
Figure 11. By Drug Type - Global HIV Therapy Price (US$/Unit), 2017-2028
Figure 12. By Application - Global HIV Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global HIV Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global HIV Therapy Price (US$/Unit), 2017-2028
Figure 15. By Region - Global HIV Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global HIV Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America HIV Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America HIV Therapy Sales Market Share, 2017-2028
Figure 19. US HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe HIV Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe HIV Therapy Sales Market Share, 2017-2028
Figure 24. Germany HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia HIV Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia HIV Therapy Sales Market Share, 2017-2028
Figure 33. China HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America HIV Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America HIV Therapy Sales Market Share, 2017-2028
Figure 40. Brazil HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa HIV Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa HIV Therapy Sales Market Share, 2017-2028
Figure 44. Turkey HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE HIV Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global HIV Therapy Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production HIV Therapy by Region, 2021 VS 2028
Figure 50. HIV Therapy Industry Value Chain
Figure 51. Marketing Channels
